CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 98 enrolled
Drug / intervention
Alcohol(oral) and placebo +1 moredrug
Likely dose
Cannabis(THC)(Inhaled) and Placebo 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01620177
NCT01620177N/ACompleted

Effects of Inhaled Cannabis on Driving Performance

Gary R Gaffney·interventional·Posted Jun 15, 2012·Updated May 2, 2018

In Brief

A clinical study evaluating Alcohol(oral) and placebo and Cannabis(THC)(Inhaled) and Placebo for Alcohol Drinking and Cannabis. Completed, enrolled 98 participants across 1 site.

Detailed Summary

The purpose of this study is to expand understanding of the effects of cannabis on driving performance with and without the presence of low levels of alcohol. This project will involve the development a of a protocol and driving environment that is sensitive to the effects of cannabis on driving performance by building on prior driving situations used previously for testing the effects of alcohol on driving.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 15, 2012
Enrollment StartJul 1, 2012
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 14.0 years ago

Interventions

Alcohol(oral) and placebodrug

Subjects will be dosed to an approximate peak BAC of 0.065%. Subjects will be tested on the decline such that subjects will be at or above the goal BAC (0.05%) throughout the drive

Cannabis(THC)(Inhaled) and Placebodrug

Cannabis vapor is produced from 500 mg either placebo (0% THC), approximately 2.5-3.5% THC (low dose), or approximately 6.0-7.5% THC (high dose) bulk cannabis plant material to yield doses of approximately 0, 12.5-17.5, or 30-37.5 mg THC